US Patent Issued to OrsoBio on Aug. 5 for "Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors" (Japanese, American Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,200, issued on Aug. 5, was assigned to OrsoBio Inc. (Palo Alto, Calif.).

"Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors" was invented by Taisuke Takahashi (Tsukuba, Japan) and Nan Ji (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to a compound represented by the following structural formula:The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of aminocarboxymuconate semialdehyde decarboxylase (ACMSD)."

The patent was filed on Aug. 9, 2023, under Application No. 18/232,198.

*F...